One amino acid change on the capsid surface of poliovirus sabin 1 allows the establishment of persistent infections in HEp-2c cell cultures

Virology

Volumn 241, Issue 1, 1998, Pages 1-13

  Pelletier, Isabelle ^a   Duncan, Gillian ^a   Colbère Garapin, Florence ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; HEP 2 CELL; HUMAN; HUMAN CELL; MISSENSE MUTATION; PERSISTENT VIRUS INFECTION; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS MUTATION;

ANIMALIA; DNA VIRUSES; MIRIDAE; POLIOVIRUS; RNA VIRUSES;

EID: 0032004895     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8954     Document Type: Article

References (26)

1. Benton P. A., Barret D. J., Matts R. L., Lloyd R. E. The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation. J. Virol. 70:1996;5525-5532.
2. Blondel B., Akacem O., Crainic R., Couillin P., Horodniceanu F. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat inactivated virions. Virology. 126:1983;707-710.
3. Borzakian S., Couderc T., Barbier Y., Attal G., Pelletier I., Colbère-Garapin F. Persistent poliovirus infection: Establishment and maintenance involve distinct mechanisms. Virology. 186:1992;398-408.
4. Borzakian S., Pelletier I., Calvez V., Colbère-Garapin F. Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells. J. Virol. 67:1993;2914-2917.
5. Calvez V., Pelletier I., Borzakian S., Colbère-Garapin F. Identification of a region of the poliovirus genome involved in persistent infection of HEp-2 cells. J. Virol. 67:1993;4432-4435.
6. Carp R. I. Persistent infection of human lymphoid cells with poliovirus and development of temperature sensitive mutants. Intervirology. 15:1981;49-56.
7. Colbère-Garapin F., Christodoulou C., Crainic R., Pelletier I. Persistent poliovirus infection of human neuroblastoma cells. Proc. Natl. Acad. Sci. USA. 86:1989;7590-7594.
8. Colston E. M., Racaniello V. R. Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition. J. Virol. 69:1995;4823-4829.
9. Couderc T., Delpeyroux J., Le Blay H., Blondel B. Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating. J. Virol. 70:1996;305-312.
10. Couderc T., Guédo N., Calvez V., Pelletier I., Hogle J., Colbère-Garapin F., Blondel B. Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice. J. Virol. 68:1994;8386-8391.
11. de la Torre J. C., Giachetti C., Semler B. L., Holland J. J. High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. Proc. Natl. Acad. Sci. USA. 89:1992;2531-2535.
12. Dove A. W., Racaniello V. R. Cold-adapted poliovirus mutants bypass a postentry replication block. J. Virol. 71:1997;4728-4735.
13. Dryga S. A., Dryga O. A., Schlesinger S. Identification of mutations in a Sindbis virus variant able to establish persistent infection in BHK cells: The importance of a mutation in the nsP2 gene. Virology. 228:1997;74-83.
14. Fichot O., Girard M. An improved method for sequencing of RNA templates. Nucleic Acids Res. 18:1990;6162.
15. Filman D. J., Syed R., Chow M., Macadam A. J., Minor P. D., Hogle J. M. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8:1989;1567-1579.
16. Flore, O. Fricks, C. E. Filman, D. J. Hogle, J. M. 1990, Conformational changes in poliovirus assembly and cell entry, In, Seminars in Virology, 1, 429, 438, Saunders, Philadelphia.
17. Higushi, R. 1990, Recombinant PCR, In, PCR Protocols: A Guide to Methods and Applications, M. InnisD. GelfandJ. SninskyT. White, 173, 183, Academic Press, San Diego.
18. Hogle J. M., Chow M., Filman D. J. Three-dimensional structure of poliovirus at 2.9 Å resolution. Science. 229:1985;1358-1365.
19. Holland J., Spindler K., Horodyski F., Grabau E., Nichol S., Van de Pol S. Rapid evolution of RNA genomes. Science. 215:1982;1577-1585.
20. Kohara M., Abe S., Kuge S., Semler B. L., Komatsu T., Arita M., Itoh H., Nomoto A. An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine. Virology. 151:1986;21-30.
21. Koike S., Horie H., Ise I., Okitsu A., Yoshida M., Iisuka N., Takeuchi K., Takegami T., Nomoto A. The poliovirus receptor protein is produced both as membrane-bound and secreted form. EMBO J. 9:1990;3217-3224.
22. Mendelsohn C., Wimmer E., Racaniello V. R. Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin superfamily. Cell. 56:1989;855-865.
23. Morrison M. E., He Y. J., Wien M. W., Hogle J. M., Racaniello V. R. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J. Virol. 68:1994;2578-2588.
24. Pelletier I., Couderc T., Borzakian S., Wyckoff E., Crainic R., Ehrenfeld E., Colbère-Garapin F. Characterization of persistent poliovirus mutants selected in human neuroblastoma cells. Virology. 180:1991;729-737.
25. Sabin A. B., Boulger L. R. History of Sabin attenuated poliovirus oral live vaccine strains. J. Biol. Stand. 1:1973;115-118.
26. Wien M. W., Curry S., Filman D. J., Hogle J. M. Structural studies of poliovirus mutants that overcome receptor defects. Nat. Struct. Biol. 4:1997;666-674.